| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | BCRX Biocryst Pharmaceuticals Inc | Abercrombie George B68 | Director | Sell | 5,000 | $15.06 | $75,300.00 | -100% | -24.2% | -14.9% | |
| Sep 15, 2021 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 1,242 | $24.55 | $30,491.10 | -1.8% | +4.5% | +226.9% | |
| Sep 14, 2021 | SNY Sanofi | Sanofi | 10% Owner | Buy | 71,983,597 | $38.00 | $2,735,376,686.00 | +122.3% | +1.0% | -14.7% | |
| Sep 13, 2021 | BCRX Biocryst Pharmaceuticals Inc | Lee Kenneth B Jr | Director | Sell | 6,000 | $15.35 | $92,100.00 | -19.8% | -25.2% | -15.0% | |
| Sep 13, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 47,000 | $0.29 | $13,663.80 | -0.1% | - | - | |
| Sep 10, 2021 | BCRX Biocryst Pharmaceuticals Inc | Abercrombie George B68 | Director | Sell | 74,000 | $15.09 | $1,116,660.00 | -100% | -22.5% | -11.5% | |
| Sep 8, 2021 | LNTH Lantheus Holdings, Inc. | Montagut Etienne51 | Chief Business Officer | Sell | 457 | $26.06 | $11,909.42 | -0.5% | +6.4% | +223.1% | |
| Sep 8, 2021 | TKNO Alpha Teknova, Inc. | Davis Ted | Director, 10% Owner | Buy | 1,300 | $22.61 | $29,392.87 | - | -14.7% | -80.5% | |
| Sep 2, 2021 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $210.94 | $1,265,649.79 | -3.8% | -10.9% | +5.0% | |
| Sep 1, 2021 | DVAX Dynavax Technologies Corp | Janssen Robert71 | Senior Vice President | Sell | 900 | $20.15 | $18,135.00 | -9.8% | -15.0% | -39.0% | |
| Sep 1, 2021 | DVAX Dynavax Technologies Corp | Burgess Justin60 | Principal Accounting Officer | Sell | 20,000 | $20.00 | $400,000.00 | -84.3% | -15.0% | -39.0% | |
| Sep 1, 2021 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 20,000 | $19.99 | $399,770.00 | -19.2% | -15.0% | -39.0% | |
| Aug 31, 2021 | AKBA Akebia Therapeutics, Inc. | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 1,042 | $2.83 | $2,948.86 | -0.6% | -10.9% | -87.6% | |
| Aug 31, 2021 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 882 | $2.98 | $2,626.68 | +0.3% | -23.6% | -18.4% | |
| Aug 31, 2021 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 315 | $2.98 | $938.10 | - | -23.6% | -18.4% | |
| Aug 31, 2021 | CPIX Cumberland Pharmaceuticals Inc | Cearnal Martin E47 | Sr Vp/ Chief Commercial Officer | Buy | 2,205 | $2.98 | $6,566.70 | - | -23.6% | -18.4% | |
| Aug 31, 2021 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth55 | Director | Buy | 1,785 | $2.98 | $5,315.90 | - | -23.6% | -18.4% | |
| Aug 31, 2021 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 315 | $2.98 | $938.10 | +0.1% | -23.6% | -18.4% | |
| Aug 31, 2021 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 2,982 | $2.98 | $8,880.68 | +0.4% | -23.6% | -18.4% | |
| Aug 30, 2021 | PAHC Phibro Animal Health Corp | Corcoran E Thomas61 | Director | Buy | 5,000 | $23.68 | $118,400.00 | +33.3% | -11.5% | -33.4% | |
| Aug 27, 2021 | ELAN Elanco Animal Health Inc | Elanco Animal Health Inc | 10% Owner | Buy | 45,508,938 | $9.25 | $420,957,676.50 | -100.0% | -9.3% | -53.8% | |
| Aug 27, 2021 | DVAX Dynavax Technologies Corp | Hack Andrew A. F.62 | Director | Sell | 2,000,000 | $16.22 | $32,440,000.00 | -19.2% | -3.5% | -33.2% | |
| Aug 27, 2021 | GTBIF Green Thumb Industries Inc. | Kovler Benjamin | Chairman &CEO | Sell | 86,792 | $30.00 | $2,603,760.00 | -10.3% | - | - | |
| Aug 25, 2021 | TKNO Alpha Teknova, Inc. | Davis Ted | Director, 10% Owner | Buy | 9,090 | $19.95 | $181,345.50 | +0.5% | +22.2% | -75.1% | |
| Aug 25, 2021 | ZTS Zoetis Inc. | Peck Kristin C66 | Chief Executive Officer | Sell | 14,500 | $203.55 | $2,951,485.58 | -19.4% | +9.5% | -18.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.